Number of cases where a second line treatment is used for either intolerance or lack of effectiveness within the 28 days after diagnosis of malaria [clinicaltrials_resource:6f15ddb5adc9eddc911df17c1f4d2329]
Malarone (atovaquone + proguanil combination):
patients treated with Malarone®
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of cases where a second line treatment is used for either intolerance or lack of effectiveness within the 28 days after diagnosis of malaria [clinicaltrials_resource:6f15ddb5adc9eddc911df17c1f4d2329]
Malarone (atovaquone + proguanil combination):
patients treated with Malarone®
Bio2RDF identifier
6f15ddb5adc9eddc911df17c1f4d2329
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6f15ddb5adc9eddc911df17c1f4d2329
measure [clinicaltrials_vocabulary:measure]
Number of cases where a second ...... rance or lack of effectiveness
time frame [clinicaltrials_vocabulary:time-frame]
within the 28 days after diagnosis of malaria
description
Malarone (atovaquone + proguanil combination):
patients treated with Malarone®
identifier
clinicaltrials_resource:6f15ddb5adc9eddc911df17c1f4d2329
title
Number of cases where a second ...... ays after diagnosis of malaria
@en
type
label
Number of cases where a second ...... 5ddb5adc9eddc911df17c1f4d2329]
@en